Cerenome vs RenovoRx
CNSY and RNXT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNSY and RNXT compare
RenovoRx is the larger company, worth 7.9 times as much as Cerenome ($43.1M against $5.4M).
Cerenome keeps more of each dollar of sales as profit, with a net margin of −621% compared with −622% at RenovoRx.
Cerenome scores higher on the StockData Score (8 against 6 for RenovoRx), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNSY | RNXT |
|---|---|---|
| Size and price | ||
| Market cap | $5.4M | $43.1M |
| Share price | $0.715 | $0.955 |
| Change, 1 year | −94.5% | −2.0% |
| Change, 5 years | −98.1% | −85.1% |
| Beta (5Y) | 4.79 | 1.24 |
| Employees | 28 | 17 |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× (better) | 21.8× |
| P/B | 1.0× (better) | 4.8× |
| FCF yield | −434% | −27.7% (better) |
| Fair value | $2.20 | – |
| Margin of safety | 67.5% | – |
| Growth | ||
| Revenue growth (TTM) | −21.0% | – |
| Profitability | ||
| Gross margin | – | 84.4% |
| Operating margin | −628% (better) | −685% |
| Net margin | −621% (better) | −622% |
| FCF margin | −560% (better) | −604% |
| Return on equity | −614% | −125% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | −1200.0× | – |
| Current ratio | 1.37 | 5.74 (better) |
| Altman Z-score | −58.32 | −0.69 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 8.3% | 20.4% |
| Held by insiders | 4.2% | 6.0% |
| Insider net buying, 12 months | $0 | $66.9K (better) |
| Short interest, % of float | 11.6% | 2.4% |
Go deeper
- CNSY stock overview
- CNSY income statement
- CNSY valuation and score
- RNXT stock overview
- RNXT income statement
- RNXT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.